Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?

被引：0
|
作者：
Roy, Akash [1 ]
Kajal, Kamal [2 ]
Izzy, Manhal [3 ]
Sihag, Bhupendra K. [4 ]
Premkumar, Madhumita [5 ,6 ]
机构：
[1] Apollo Multispecial Hosp, Inst Gastrosciences & Liver, Dept Hepatol, Kolkata, West Bengal, India
[2] Postgrad Inst Med Educ & Res, Dept Anesthesia & Intens Care, Chandigarh, India
[3] Vanderbilt Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN USA
[4] Postgrad Inst Med Educ & Res, Dept Cardiol, Chandigarh, India
[5] Postgrad Inst Med Educ & Res, Dept Hepatol, Chandigarh, India
[6] Postgrad Inst Med Educ & Res, Dept Hepatol, Chandigarh 160012, India
来源：
HEPATOLOGY | 2024年 / 79卷 / 06期
关键词：
HYPERTENSION;
D O I：
10.1097/HEP.0000000000000833
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：E163 / E164
页数：2
相关论文
共 50 条
  • [1] Letter to the Editor: Is right heart assessment vital for evaluating terlipressin-related outcomes in hepatorenal syndrome-acute kidney injury?
    Guo, Qirui
    Wang, Jie
    Wang, Guangjian
    Wang, Xiaoting
    HEPATOLOGY, 2024, 79 (06) : E161 - E162
  • [2] Reply: Regarding terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury
    Premkumar, Madhumita
    Kulkarni, Anand
    Izzy, Manhal
    HEPATOLOGY, 2024,
  • [3] Regarding terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury
    Luo, Xin
    Yu, Jixian
    HEPATOLOGY, 2024,
  • [4] Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography
    Premkumar, Madhumita
    Kajal, Kamal
    Reddy, K. Rajender
    Izzy, Manhal
    Kulkarni, Anand V.
    Duseja, Ajay Kumar
    Sihag, K. Bhupendra
    Divyaveer, Smita
    Gupta, Ankur
    Taneja, Sunil
    De, Arka
    Verma, Nipun
    Rathi, Sahaj
    Bhujade, Harish
    Chaluvashetty, Sreedhara B.
    Roy, Akash
    Kumar, Vishesh
    Siddhartha, Vuppada
    Singh, Virendra
    Bahl, Ajay
    HEPATOLOGY, 2024, 79 (05) : 1048 - 1064
  • [5] Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis
    Florence Wong
    Stephen C. Pappas
    Intensive Care Medicine, 2025, 51 (1) : 213 - 214
  • [6] From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury
    Allegretti, Andrew S.
    Patidar, Kavish R.
    Ma, Ann T.
    Cullaro, Giuseppe
    HEPATOLOGY, 2024,
  • [7] NOVEL PREDICTORS OF RESPONSE TO THERAPY WITH TERLIPRESSIN AND ALBUMIN IN HEPATORENAL SYNDROME-ACUTE KIDNEY INJURY
    Narayanan, Vijay
    Devadas, Krishnadas
    Solanki, Rushil
    Pal, Ravindra
    Mohapatra, Shivabrata Dhal
    Chakravorty, Avisek
    Madhu, Devika
    HEPATOLOGY, 2022, 76 : S1212 - S1213
  • [8] Novel predictors of response to therapy with terlipressin and albumin in hepatorenal syndrome-acute kidney injury
    Narayanan, Vijay
    Devadas, Krishnadas
    Sreesh, Srijaya
    Varghese, Jijo
    Solanki, Rushil
    Mohapatra, Shivabrata Dhal
    Pal, Ravindra
    Madhu, Devika
    Chakravorty, Avisek
    ANNALS OF GASTROENTEROLOGY, 2024, 37 (01): : 81 - 88
  • [9] Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)
    Kulkarni, Anand V.
    Lee, Jason
    Reddy, K. Rajender
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (11) : 1067 - 1079
  • [10] The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin
    Flamm, Steven L.
    Brown, Kimberly
    Wadei, Hani M.
    Brown, Robert S., Jr.
    Kugelmas, Marcelo
    Samaniego-Picota, Milagros
    Burra, Patrizia
    Poordad, Fred
    Saab, Sammy
    LIVER TRANSPLANTATION, 2021, 27 (08) : 1191 - 1202
12345